Article
Drug resistance is uncommon in pregnant women with low viral loads taking zidovudine monotherapy to prevent perinatal HIV transmission.
AIDS (London, England) - 5 Dec 2003
Larbalestier Nick, Mullen Jane, O'Shea Siobhan, Cottam Fiona, Sabin Caroline A, Chrystie Ian L, Welch Jan, Zuckerman Mark, Hay Phillip, Rice Phillip, Taylor Graham P, de Ruiter Annemiek
Abstract excerpt
Zidovudine monotherapy is used to reduce perinatal HIV transmission in women with low viral loads. There are few data on the risk of drug resistance in this select cohort of women. We determined the prevalence of newly acquired mutations conferring reduced sensitivity to zidovudine after exposure during pregnancy, and found that the development of mutations was uncommon and was restricted to women treated before...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.